English
简体中文
Total: £ 56.28
Published Date: 2025-03-25 | Pages: 96 | Tables: 99 | Medical Care
The global market for Embolotherapy was valued at US$ 4355 million in the year 2024 and is projected to reach a revised size of US$ 6948 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Global key players of Embolotherapy include Medtronic, Boston Scientific, etc. Global top 3 companies hold a share over 30%. North America is the largest market, with a share about 35%, followed by Europe and China with the share about 25% and 20%. In terms of product, Microspheres for Embolization is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer, with a share about 50%.
This report aims to provide a comprehensive presentation of the global market for Embolotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolotherapy.
The Embolotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Embolotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Segment by Type
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Segment by Application
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Embolotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Embolotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microspheres for Embolization
1.2.3 Embolism Particles
1.2.4 Embolic coils
1.2.5 Liquid Embolic Agent
1.2.6 Auxiliary Embolization Material
1.2.7 Others
1.3 Market by Application
1.3.1 Global Embolotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Peripheral Aascular Disease
1.3.4 Nerve System Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Embolotherapy Market Perspective (2020-2031)
2.2 Global Embolotherapy Growth Trends by Region
2.2.1 Global Embolotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Embolotherapy Historic Market Size by Region (2020-2025)
2.2.3 Embolotherapy Forecasted Market Size by Region (2026-2031)
2.3 Embolotherapy Market Dynamics
2.3.1 Embolotherapy Industry Trends
2.3.2 Embolotherapy Market Drivers
2.3.3 Embolotherapy Market Challenges
2.3.4 Embolotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Embolotherapy Players by Revenue
3.1.1 Global Top Embolotherapy Players by Revenue (2020-2025)
3.1.2 Global Embolotherapy Revenue Market Share by Players (2020-2025)
3.2 Global Embolotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Embolotherapy Revenue
3.4 Global Embolotherapy Market Concentration Ratio
3.4.1 Global Embolotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Embolotherapy Revenue in 2024
3.5 Global Key Players of Embolotherapy Head office and Area Served
3.6 Global Key Players of Embolotherapy, Product and Application
3.7 Global Key Players of Embolotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Embolotherapy Breakdown Data by Type
4.1 Global Embolotherapy Historic Market Size by Type (2020-2025)
4.2 Global Embolotherapy Forecasted Market Size by Type (2026-2031)
5 Embolotherapy Breakdown Data by Application
5.1 Global Embolotherapy Historic Market Size by Application (2020-2025)
5.2 Global Embolotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Embolotherapy Market Size (2020-2031)
6.2 North America Embolotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Embolotherapy Market Size by Country (2020-2025)
6.4 North America Embolotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Embolotherapy Market Size (2020-2031)
7.2 Europe Embolotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Embolotherapy Market Size by Country (2020-2025)
7.4 Europe Embolotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Embolotherapy Market Size (2020-2031)
8.2 Asia-Pacific Embolotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Embolotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Embolotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Embolotherapy Market Size (2020-2031)
9.2 Latin America Embolotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Embolotherapy Market Size by Country (2020-2025)
9.4 Latin America Embolotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Embolotherapy Market Size (2020-2031)
10.2 Middle East & Africa Embolotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Embolotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Embolotherapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Embolotherapy Introduction
11.1.4 Medtronic Revenue in Embolotherapy Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Embolotherapy Introduction
11.2.4 Boston Scientific Revenue in Embolotherapy Business (2020-2025)
11.2.5 Boston Scientific Recent Development
11.3 Terumo
11.3.1 Terumo Company Details
11.3.2 Terumo Business Overview
11.3.3 Terumo Embolotherapy Introduction
11.3.4 Terumo Revenue in Embolotherapy Business (2020-2025)
11.3.5 Terumo Recent Development
11.4 Penumbra, Inc.
11.4.1 Penumbra, Inc. Company Details
11.4.2 Penumbra, Inc. Business Overview
11.4.3 Penumbra, Inc. Embolotherapy Introduction
11.4.4 Penumbra, Inc. Revenue in Embolotherapy Business (2020-2025)
11.4.5 Penumbra, Inc. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Embolotherapy Introduction
11.5.4 Johnson & Johnson Revenue in Embolotherapy Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Sirtex
11.6.1 Sirtex Company Details
11.6.2 Sirtex Business Overview
11.6.3 Sirtex Embolotherapy Introduction
11.6.4 Sirtex Revenue in Embolotherapy Business (2020-2025)
11.6.5 Sirtex Recent Development
11.7 Merit Medical
11.7.1 Merit Medical Company Details
11.7.2 Merit Medical Business Overview
11.7.3 Merit Medical Embolotherapy Introduction
11.7.4 Merit Medical Revenue in Embolotherapy Business (2020-2025)
11.7.5 Merit Medical Recent Development
11.8 Varian
11.8.1 Varian Company Details
11.8.2 Varian Business Overview
11.8.3 Varian Embolotherapy Introduction
11.8.4 Varian Revenue in Embolotherapy Business (2020-2025)
11.8.5 Varian Recent Development
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Embolotherapy Introduction
11.9.4 Stryker Revenue in Embolotherapy Business (2020-2025)
11.9.5 Stryker Recent Development
11.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
11.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Details
11.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
11.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Introduction
11.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2020-2025)
11.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
11.11 Cook Medical
11.11.1 Cook Medical Company Details
11.11.2 Cook Medical Business Overview
11.11.3 Cook Medical Embolotherapy Introduction
11.11.4 Cook Medical Revenue in Embolotherapy Business (2020-2025)
11.11.5 Cook Medical Recent Development
11.12 Kaneka
11.12.1 Kaneka Company Details
11.12.2 Kaneka Business Overview
11.12.3 Kaneka Embolotherapy Introduction
11.12.4 Kaneka Revenue in Embolotherapy Business (2020-2025)
11.12.5 Kaneka Recent Development
11.13 Meril Life Sciences
11.13.1 Meril Life Sciences Company Details
11.13.2 Meril Life Sciences Business Overview
11.13.3 Meril Life Sciences Embolotherapy Introduction
11.13.4 Meril Life Sciences Revenue in Embolotherapy Business (2020-2025)
11.13.5 Meril Life Sciences Recent Development
11.14 Peijia Medical Limited
11.14.1 Peijia Medical Limited Company Details
11.14.2 Peijia Medical Limited Business Overview
11.14.3 Peijia Medical Limited Embolotherapy Introduction
11.14.4 Peijia Medical Limited Revenue in Embolotherapy Business (2020-2025)
11.14.5 Peijia Medical Limited Recent Development
11.15 Wallaby Medical
11.15.1 Wallaby Medical Company Details
11.15.2 Wallaby Medical Business Overview
11.15.3 Wallaby Medical Embolotherapy Introduction
11.15.4 Wallaby Medical Revenue in Embolotherapy Business (2020-2025)
11.15.5 Wallaby Medical Recent Development
11.16 MicroPort Scientific Corporation
11.16.1 MicroPort Scientific Corporation Company Details
11.16.2 MicroPort Scientific Corporation Business Overview
11.16.3 MicroPort Scientific Corporation Embolotherapy Introduction
11.16.4 MicroPort Scientific Corporation Revenue in Embolotherapy Business (2020-2025)
11.16.5 MicroPort Scientific Corporation Recent Development
11.17 Shandong Visee Medical Devices Co.,Ltd
11.17.1 Shandong Visee Medical Devices Co.,Ltd Company Details
11.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
11.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Introduction
11.17.4 Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2020-2025)
11.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Development
11.18 Beijing Taijie Weiye Technology
11.18.1 Beijing Taijie Weiye Technology Company Details
11.18.2 Beijing Taijie Weiye Technology Business Overview
11.18.3 Beijing Taijie Weiye Technology Embolotherapy Introduction
11.18.4 Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2020-2025)
11.18.5 Beijing Taijie Weiye Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Embolotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Microspheres for Embolization
Table 3. Key Players of Embolism Particles
Table 4. Key Players of Embolic coils
Table 5. Key Players of Liquid Embolic Agent
Table 6. Key Players of Auxiliary Embolization Material
Table 7. Key Players of Others
Table 8. Global Embolotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Embolotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Embolotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Embolotherapy Market Share by Region (2020-2025)
Table 12. Global Embolotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Embolotherapy Market Share by Region (2026-2031)
Table 14. Embolotherapy Market Trends
Table 15. Embolotherapy Market Drivers
Table 16. Embolotherapy Market Challenges
Table 17. Embolotherapy Market Restraints
Table 18. Global Embolotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Embolotherapy Market Share by Players (2020-2025)
Table 20. Global Top Embolotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolotherapy as of 2024)
Table 21. Ranking of Global Top Embolotherapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Embolotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Embolotherapy, Headquarters and Area Served
Table 24. Global Key Players of Embolotherapy, Product and Application
Table 25. Global Key Players of Embolotherapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Embolotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Embolotherapy Revenue Market Share by Type (2020-2025)
Table 29. Global Embolotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Embolotherapy Revenue Market Share by Type (2026-2031)
Table 31. Global Embolotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Embolotherapy Revenue Market Share by Application (2020-2025)
Table 33. Global Embolotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Embolotherapy Revenue Market Share by Application (2026-2031)
Table 35. North America Embolotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Embolotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Embolotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Embolotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Embolotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Embolotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Embolotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Embolotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Embolotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Embolotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Embolotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Embolotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Embolotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Embolotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Embolotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 50. Medtronic Company Details
Table 51. Medtronic Business Overview
Table 52. Medtronic Embolotherapy Product
Table 53. Medtronic Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 54. Medtronic Recent Development
Table 55. Boston Scientific Company Details
Table 56. Boston Scientific Business Overview
Table 57. Boston Scientific Embolotherapy Product
Table 58. Boston Scientific Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 59. Boston Scientific Recent Development
Table 60. Terumo Company Details
Table 61. Terumo Business Overview
Table 62. Terumo Embolotherapy Product
Table 63. Terumo Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 64. Terumo Recent Development
Table 65. Penumbra, Inc. Company Details
Table 66. Penumbra, Inc. Business Overview
Table 67. Penumbra, Inc. Embolotherapy Product
Table 68. Penumbra, Inc. Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 69. Penumbra, Inc. Recent Development
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Embolotherapy Product
Table 73. Johnson & Johnson Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 74. Johnson & Johnson Recent Development
Table 75. Sirtex Company Details
Table 76. Sirtex Business Overview
Table 77. Sirtex Embolotherapy Product
Table 78. Sirtex Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 79. Sirtex Recent Development
Table 80. Merit Medical Company Details
Table 81. Merit Medical Business Overview
Table 82. Merit Medical Embolotherapy Product
Table 83. Merit Medical Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 84. Merit Medical Recent Development
Table 85. Varian Company Details
Table 86. Varian Business Overview
Table 87. Varian Embolotherapy Product
Table 88. Varian Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 89. Varian Recent Development
Table 90. Stryker Company Details
Table 91. Stryker Business Overview
Table 92. Stryker Embolotherapy Product
Table 93. Stryker Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 94. Stryker Recent Development
Table 95. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Details
Table 96. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
Table 97. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product
Table 98. Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 99. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
Table 100. Cook Medical Company Details
Table 101. Cook Medical Business Overview
Table 102. Cook Medical Embolotherapy Product
Table 103. Cook Medical Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 104. Cook Medical Recent Development
Table 105. Kaneka Company Details
Table 106. Kaneka Business Overview
Table 107. Kaneka Embolotherapy Product
Table 108. Kaneka Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 109. Kaneka Recent Development
Table 110. Meril Life Sciences Company Details
Table 111. Meril Life Sciences Business Overview
Table 112. Meril Life Sciences Embolotherapy Product
Table 113. Meril Life Sciences Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 114. Meril Life Sciences Recent Development
Table 115. Peijia Medical Limited Company Details
Table 116. Peijia Medical Limited Business Overview
Table 117. Peijia Medical Limited Embolotherapy Product
Table 118. Peijia Medical Limited Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 119. Peijia Medical Limited Recent Development
Table 120. Wallaby Medical Company Details
Table 121. Wallaby Medical Business Overview
Table 122. Wallaby Medical Embolotherapy Product
Table 123. Wallaby Medical Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 124. Wallaby Medical Recent Development
Table 125. MicroPort Scientific Corporation Company Details
Table 126. MicroPort Scientific Corporation Business Overview
Table 127. MicroPort Scientific Corporation Embolotherapy Product
Table 128. MicroPort Scientific Corporation Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 129. MicroPort Scientific Corporation Recent Development
Table 130. Shandong Visee Medical Devices Co.,Ltd Company Details
Table 131. Shandong Visee Medical Devices Co.,Ltd Business Overview
Table 132. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product
Table 133. Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 134. Shandong Visee Medical Devices Co.,Ltd Recent Development
Table 135. Beijing Taijie Weiye Technology Company Details
Table 136. Beijing Taijie Weiye Technology Business Overview
Table 137. Beijing Taijie Weiye Technology Embolotherapy Product
Table 138. Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2020-2025) & (US$ Million)
Table 139. Beijing Taijie Weiye Technology Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Authors List of This Report
List of Figures
Figure 1. Embolotherapy Picture
Figure 2. Global Embolotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Embolotherapy Market Share by Type: 2024 VS 2031
Figure 4. Microspheres for Embolization Features
Figure 5. Embolism Particles Features
Figure 6. Embolic coils Features
Figure 7. Liquid Embolic Agent Features
Figure 8. Auxiliary Embolization Material Features
Figure 9. Others Features
Figure 10. Global Embolotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Embolotherapy Market Share by Application: 2024 VS 2031
Figure 12. Cancer Case Studies
Figure 13. Peripheral Aascular Disease Case Studies
Figure 14. Nerve System Disease Case Studies
Figure 15. Others Case Studies
Figure 16. Embolotherapy Report Years Considered
Figure 17. Global Embolotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Embolotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Embolotherapy Market Share by Region: 2024 VS 2031
Figure 20. Global Embolotherapy Market Share by Players in 2024
Figure 21. Global Top Embolotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolotherapy as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Embolotherapy Revenue in 2024
Figure 23. North America Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Embolotherapy Market Share by Country (2020-2031)
Figure 25. United States Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Embolotherapy Market Share by Country (2020-2031)
Figure 29. Germany Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Embolotherapy Market Share by Region (2020-2031)
Figure 37. China Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Embolotherapy Market Share by Country (2020-2031)
Figure 45. Mexico Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Embolotherapy Market Share by Country (2020-2031)
Figure 49. Turkey Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Embolotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Medtronic Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 53. Boston Scientific Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 54. Terumo Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 55. Penumbra, Inc. Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 56. Johnson & Johnson Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 57. Sirtex Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 58. Merit Medical Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 59. Varian Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 60. Stryker Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 61. Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 62. Cook Medical Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 63. Kaneka Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 64. Meril Life Sciences Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 65. Peijia Medical Limited Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 66. Wallaby Medical Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 67. MicroPort Scientific Corporation Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 68. Shandong Visee Medical Devices Co.,Ltd Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 69. Beijing Taijie Weiye Technology Revenue Growth Rate in Embolotherapy Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
